Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2003
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093244A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003WO2003093241A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003093236A1 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003093223A1 Biphenyl carboxamides
11/13/2003WO2003092698A1 A process for the preparation of benazepril hydrochloride
11/13/2003WO2003092692A1 Therapeutic agent comprising lafutidine
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003057688A3 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators
11/13/2003WO2003053331A3 Protease inhibitors
11/13/2003WO2003041644A3 Method to treat cystic fibrosis
11/13/2003WO2003035617A3 Derivatives of uk-2a
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003US20030212279 Anticholesterol agents
11/13/2003US20030212278 Using dihydropyran, triethyl orthoformate and alkyl acrylate
11/13/2003US20030212276 Process for the preparation of 7-substituted-3 quinolinecarbonitriles
11/13/2003US20030212121 Antiproliferative agents; anticancer agents; autoimmune diseases; cardiovascular disorders
11/13/2003US20030212119 Novel glucagon receptor antagonists/inverse agonists
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212090 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
11/13/2003US20030212089 Arylindenopyridines and related therapeutic and prophylactic methods
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212057 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
11/13/2003US20030212056 Rheumatic diseases; osteoporosis; antiulcer agents; antiulcer agents; antitumor agents; antiinflammatory agents
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2484585A1 A process for the preparation of benazepril hydrochloride
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484280A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483529A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1037881B1 Process of preparing substituted pyrimidinones
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
11/12/2003CN1127502C Salts of paroxetine
11/12/2003CN1127501C Indole and 2,3-dihydroninbole derivatives, their preparation and use
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646136 Chemical intermediates for CNS drugs
11/11/2003US6646129 Cyanoguanidines as cell proliferation inhibitors
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645983 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645972 Administering nucleoside analogues such as beta-L-dioxolane cytidine as tyrosine kinase inhibitors or anticarcinogenic agents
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/11/2003US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors
11/11/2003US6645594 Formazan metal complex
11/11/2003CA2113424C Muscarinic agonists
11/11/2003CA2078811C Sulphonylaminocarbonyltriazolinones having two substituents bonded via oxygen
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091246A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof
11/06/2003WO2003091236A1 Imidazolinylmethyl aralkylsulfonamides
11/06/2003WO2003091231A1 Pna monomer and precursor
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091219A1 Isoquinoline derivatives
1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 694